Archive › BNTX
BNTX trade ideas: every closed DuckWise idea on BioNTech SE
DuckWise has published 2 ideas on BioNTech SE (BNTX, Stock) that have closed between January 2021 and November 2021. Each is listed below with the levels published before the position was taken and its result at close — 2 in profit, 0 at a loss.
| Opened | Closed | Side | Entry | Stop | Projection | Close | Result | Days |
|---|---|---|---|---|---|---|---|---|
| Nov 2, 2021 | Nov 26, 2021 | Long | 281.94 | — | 334 | 350.57 | +24.34% | 24 |
| Jan 11, 2021 | Apr 16, 2021 | Long | 108.45 | — | 146.50 | 151.10 | +39.33% | 95 |
Prices in US dollars. Prices are as traded on the day. Result is the price change from the published entry to the published close plus dividends received while the idea was held (paid, for shorts), before fees, taxes and slippage. How results are counted.
BNTX questions and answers
Has DuckWise published trade ideas on BNTX?
Yes. DuckWise has published 2 ideas on BioNTech SE (BNTX) that closed between January 2021 and November 2021: 2 closed in profit and 0 at a loss. The average result was +31.84% from the published entry to the published close, dividends included.
What was the latest closed DuckWise idea on BNTX?
A long idea opened on November 2, 2021 with an entry of $281.94 and a price projection of $334.00. It closed on November 26, 2021 at $350.57, a result of +24.34% after 24 days.
How long did DuckWise hold its BNTX ideas?
The typical BNTX idea was held about 95 days from entry to close. DuckWise ideas are swing and position trades, not day trades.
Is there an open DuckWise idea on BNTX right now?
Not at the moment. When DuckWise publishes a new idea on BNTX, app subscribers get a push notification; it appears on this page once it closes.
Is this page a stock forecast for BNTX or a recommendation to buy it?
No. This page records closed ideas only. Each price projection was a published level for a model idea, not a forecast of where BNTX will trade. The research is general and impersonal, not a recommendation to buy or sell BNTX or any other security.
More trade ideas on the record
- BLK BlackRock, Inc. · 1 idea
- BLUE bluebird bio, Inc. · 1 idea
- BMY Bristol-Myers Squibb Company · 2 ideas
- BRK.B Berkshire Hathaway Inc. New · 1 idea
- BTC Bitcoin · 6 ideas
- CAT Caterpillar, Inc. · 1 idea
- AMZN Amazon.com, Inc. · 25 ideas
- TSLA Tesla, Inc. · 22 ideas
- CRM Salesforce, Inc. · 18 ideas
- LRCX Lam Research Corporation · 16 ideas
- GOOG Alphabet Inc. · 15 ideas
- ON ON Semiconductor Corporation · 15 ideas
- AAPL Apple Inc. · 14 ideas
- AMD Advanced Micro Devices, Inc. · 14 ideas
Every ticker in the archive · Track record by year
About BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. Does not pay dividends.
These are closed ideas, published for the record. They are general and impersonal research, not a recommendation to buy or sell BNTX or any other security.
DuckWise